SBI Securities’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.9K Buy
715
+452
+172% +$13.3K ﹤0.01% 1453
2026
Q1
$6.49K Buy
263
+253
+2,530% +$4.42K ﹤0.01% 1912
2025
Q4
$169 Sell
10
-118
-92% -$2.08K ﹤0.01% 3262
2025
Q3
$2.78K Buy
128
+26
+25% +$431 ﹤0.01% 2293
2025
Q2
$1.45K Buy
102
+2
+2% +$32 ﹤0.01% 2525
2025
Q1
$1.3K Sell
100
-41
-29% -$619 ﹤0.01% 2473
2024
Q4
$1.88K Buy
+141
New +$1.43K ﹤0.01% 2336

Other funds holding ETON

SBI Securities's ETON Position: Q2 2026 in Review

SBI Securities increased its Eton Pharmaceutcials (ETON) stake by 172% in Q2 2026, buying an estimated $13.3K and bringing the position to 715 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1453.

SBI Securities first reported a position in ETON in Q4 2024 and has held it in 7 quarters since. 59 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • SBI Securities held 715 shares of Eton Pharmaceutcials worth $25.9K as of Q2 2026.
  • SBI Securities bought 452 Eton Pharmaceutcials shares in Q2 2026, an estimated $13.3K.
  • Eton Pharmaceutcials made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1453 holding.
  • SBI Securities first reported a position in Eton Pharmaceutcials in Q4 2024 and has held it in 7 quarters since.
  • 59 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.